Table 1. Dose escalation of 5-FU 24-hour EPIC for each titration level and concomitant treatment where irinotecan is also an investigational drug (the other drugs are non-investigational and given to both groups in the randomized part of the trial).
Level | Non-investigational Oxaliplatin |
Investigational Irinotecan |
Investigational 5-FU 24-hour EPIC |
Non-investigational 5-FU bolus |
Non-investigational Calcium folinate |
---|---|---|---|---|---|
-1 | 360 mg/m2 | 360 mg/m 2 | 250 mg/m 2 | 400 mg/m2 | 60mg/m2 |
0 | 360 mg/m2 | 360 mg/m 2 | 400 mg/m 2 | 400 mg/m2 | 60mg/m2 |
1 | 360 mg/m2 | 360 mg/m 2 | 550 mg/m 2 | 400 mg/m2 | 60mg/m2 |
2 | 360 mg/m2 | 360 mg/m 2 | 700 mg/m 2 | 400 mg/m2 | 60mg/m2 |
3 | 360 mg/m2 | 360 mg/m 2 | 850 mg/m 2 | 400 mg/m2 | 60mg/m2 |